Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS

NCT04745299

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Pusan National University Yangsan Hospital Yangsan, Kyungsangnam-do, South Korea
  • Hanyang university hospital Seoul, South Korea
  • Korea University Anam Hospital Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details
Completed

Muscle Oxygenation in Effort in Neuromuscular Diseases

NCT02789059

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
Locations
  • Hôpital Amiens Nord, Service de Neurologie Amiens, France
  • CHRU de Lille, Hôpital Swyngedhauw Lille, France
  • Hôpital Sébastopol, CHU de Reims Reims, France
View Trial Details
Completed

A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD

NCT04993755

Conditions
Amyotrophic Lateral Sclerosis, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • University of California San Diego La Jolla, California, United States
  • University of California Irvine - ALS & Neuromuscular Center Orange, California, United States
  • UCSF Neurosciences Clinical Research Unit (NCRU) San Francisco, California, United States
  • John Hopkins University Baltimore, Maryland, United States
View all 19 locations
View Trial Details

Related conditions